Pran Kishore Deb 个人学术档案

引用次数

	总计	2019 年至今
引用	2882	2510
h 指数	30	29
i10 指数	79	75

640

320

160

480

201120122013201420152016201720182019202020212022202320248 25 31 53 45 49 59 75 234 290 464 538 638 339

开放获取的出版物数量

查看全部

16 篇文章

可查看的文章

无法查看的文章

根据资助方的强制性开放获取政策

合著作者

Katharigatta Narayanaswamy Venugo...King Faisal University在 kfu.edu.sa 的电子邮件经过验证
Dr. Rakesh K. Tekade (Associate Prof...NIPER-A, IIT-Jammu, UTSouthwestern Texas (USA); University of Hawaii (USA), UCLan (UK), IMU-Malaysia在 niperahm.ac.in 的电子邮件经过验证
Anroop B NairKing Faisal University在 kfu.edu.sa 的电子邮件经过验证
Mailavaram Raghu PrasadProfessor of Pharmaceutical Chemistry, Shri Vishnu College of Pharmacy, Andhra University在 svcp.edu.in 的电子邮件经过验证
Balakumar ChandrasekaranProfessor-Faculty of Pharmacy, Philadelphia University, Amman, Jordan在 philadelphia.edu.jo 的电子邮件经过验证
Sandeep ChandrashekharappaNational Institute of Pharmaceutical Education and Research, Raebareli, (NIPER-R)在 niperraebareli.edu.in 的电子邮件经过验证
Kaki Venkata RaoAssistant Professor, NIPER, Hyderabad在 niperhyd.ac.in 的电子邮件经过验证
Nizar Al-Shar'iProfessor of Medicinal Chemistry and Computer-Aided Drug Design在 just.edu.jo 的电子邮件经过验证
Dr Rajwinder KaurProfessor, Chitkara College of Pharmacy, Chitkara University Punjab在 chitkara.edu.in 的电子邮件经过验证
Sara Nidal AbedLoughborough University在 student.lboro.ac.uk 的电子邮件经过验证
Raghuram Rao AkkinepallyProfessor, University College of Pharmaceutical Sciences, Kakatiya University在 kakatiya.ac.in 的电子邮件经过验证
Deepak ChopraProfessor在 iiserb.ac.in 的电子邮件经过验证
Vinayak SinghSenior Research Officer, Drug Discovery & Development Centre (H3D), University of Cape Town在 uct.ac.za 的电子邮件经过验证
A M Y JaberPhiladelphia University Jordan在 philadelphia.edu.jo 的电子邮件经过验证
Lina A. DahabiyehAssociate Professor of Bioanalysis and Pharmaceutical Analysis, The University of Jordan在 ju.edu.jo 的电子邮件经过验证
Sarah Falah KokazMaster degree in Medicinal chemistry在 ankara.edu.tr 的电子邮件经过验证
Anant ParadkarCentre for Pharmaceutical Engineering Science, University of Bradford在 bradford.ac.uk 的电子邮件经过验证
Johnson StanslasUniversiti Putra Malaysia在 upm.edu.my 的电子邮件经过验证
Bapi GorainBirla Institute of Technology, Mesra, Ranchi; Taylor's University, Malaysia在 bitmesra.ac.in 的电子邮件经过验证
VINOD TIWARI, Ph.D, FRSB, Associat...IIT (B.H.U), Varanasi; NIPER-Ahmedabad; Johns Hopkins Medicine (USA); UIPS, Panjab University在 iitbhu.ac.in 的电子邮件经过验证

关注

Pran Kishore Deb

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi

在 bitmesra.ac.in 的电子邮件经过验证

Medicinal Chemistry


标题按引用次数排序按年份排序按标题排序	引用次数引用次数	年份
Synthesis, anti-inflammatory evaluation and docking studies of some new fluorinated fused quinazolines C Balakumar, P Lamba, D Pran Kishore, BL Narayana, KV Rao, ... European journal of medicinal chemistry 45 (11), 4904-4913, 2010	207	2010
Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer M Shubhangi, P Abhimanyu, K Kaushik, M Rahul, D Pran Kishore, K Kiran, ... International Journal of Pharmaceutics 584 (1), 540-558, 2018	133*	2018
Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents D Aakash, KB Richa, K Ramanjot, K Sanjiv, KJ Upendra, S Harinder, ... Current Topics in Medicinal Chemistry 17 (2), 238-250, 2017	120	2017
Molecular dynamics simulation strategies for designing carbon-nanotube-based targeted drug delivery AQ Mohammed N, D Pran Kishore, T Rakesh K. Drug Discovery Today 23 (2), 235-250, 2018	91	2018
Pharmaceutical and biomedical applications of polymers D Pran Kishore, SF Kokaz, SN Abed, A Paradkar, RK Tekade Basic Fundamentals of Drug Delivery, 203-267, 2019	72	2019
Protein/peptide drug delivery systems: practical considerations in pharmaceutical product development D Pran Kishore, O Al-Attraqchi, B Chandrasekaran, A Paradkar, ... Basic Fundamentals of Drug Delivery, 651-684, 2019	60	2019
Thiazole: A versatile standalone moiety contributing to the development of various drugs and biologically active agents MF Arshad, A Alam, AA Alshammari, MB Alhazza, IM Alzimam, MA Alam, ... Molecules 27 (13), 3994, 2022	59	2022
Synthesis, anti-inflammatory evaluation, and docking studies of some new thiazole derivatives D Pran Kishore, R Kaur, B Chandrasekaran, M Bala, D Gill, VR Kaki, ... Medicinal Chemistry Research 23 (6), 2780-2792, 2014	55	2014
Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: navigating the uncharted P Borah, PK Deb, B Chandrasekaran, M Goyal, M Bansal, S Hussain, ... Frontiers in molecular biosciences 8, 627723, 2021	54	2021
ADMET profiling in drug discovery and development: perspectives of in silico, in vitro and integrated approaches NEH Daoud, P Borah, PK Deb, KN Venugopala, W Hourani, M Alzweiri, ... Current Drug Metabolism 22 (7), 503-522, 2021	51	2021
QSAR of adenosine receptor antagonists: exploring physicochemical requirements for binding of pyrazolo [4, 3-e]-1, 2, 4-triazolo [1, 5-c] pyrimidine derivatives with human … D Pran Kishore, C Balakumar, AR Rao, PP Roy, K Roy Bioorganic & medicinal chemistry letters 21 (2), 818-823, 2011	48	2011
Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors D Pran Kishore, A Sharma, P Piplani, RR Akkinepally Molecular diversity 16, 803-823, 2012	47	2012
Exploring the potential of carbon dots to combat COVID-19 S Kotta, HM Aldawsari, SM Badr-Eldin, NA Alhakamy, S Md, AB Nair, ... Frontiers in Molecular Biosciences 7, 616575, 2020	46	2020
Three-dimensional in vitro cell culture models for efficient drug discovery: Progress so far and future prospects SM Badr-Eldin, HM Aldawsari, S Kotta, PK Deb, KN Venugopala Pharmaceuticals 15 (8), 926, 2022	45	2022
Medicinal chemistry and therapeutic potential of agonists, antagonists and allosteric modulators of A1 adenosine receptor: Current status and perspectives D Pran Kishore, S Deka, P Borah, SN Abed, KN Klotz Current pharmaceutical design 25 (25), 2697-2715, 2019	45	2019
Molecular Modeling Evaluation of Non‐Steroidal Aromatase Inhibitors^† BL Narayana, D Pran Kishore, C Balakumar, KV Rao, R Kaur, AR Rao, ... Chemical Biology & Drug Design 79 (5), 674-682, 2012	43	2012
Perspectives on RNA vaccine candidates for COVID-19 P Borah, PK Deb, NA Al-Shar’i, LA Dahabiyeh, KN Venugopala, V Singh, ... Frontiers in Molecular Biosciences 8, 635245, 2021	41	2021
Dendrimer-based nanocarriers in lung Cancer therapy B Gorain, H Choudhury, M Pandey, AB Nair, MCIM Amin, N Molugulu, ... Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer, 161-192, 2019	41	2019
Cytotoxicity and Antimycobacterial Properties of Pyrrolo [1, 2-a] quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies KN Venugopala, V Uppar, S Chandrashekharappa, HH Abdallah, M Pillay, ... Antibiotics 9 (5), 233, 2020	39	2020
Selective COX-2 inhibitors: road from success to controversy and the quest for repurposing AA El-Malah, MM Gineinah, PK Deb, AN Khayyat, M Bansal, ... Pharmaceuticals 15 (7), 827, 2022	38	2022

系统目前无法执行此操作，请稍后再试。

文章 1–20

每年引用数

重复的引用

合并的引用

添加合著者合著作者

上传 PDF

关注此作者

引用次数

合著作者

引用